|
|
| News Archive |
OGT Signs Licensing Deal for Colorectal Cancer Biomarkers
Thursday, February 23, 2012
OGT has entered into an exclusive licensing agreement with Inven2.
NIH Common Fund Researchers Uncover Structure of Important Target for Drug Design
Tuesday, February 21, 2012
Researchers have uncovered a potent class of small molecules that selectively turn on the S1P1 receptor.
Evotec and IR Pharma Establish Drug Discovery Alliance
Thursday, February 16, 2012
Companies have entered into an exclusive strategic alliance to provide integrated drug discovery solutions to Pharmaceutical and Biotech companies in the field of Respiratory Diseases.
BD Diagnostics Expands Portfolio with Automated Instrumentation Technologies
Thursday, February 16, 2012
Company announced the expansion of its microbiology portfolio to include new automated instrumentation technologies that will enable the Company to offer innovative total lab automation solutions to hospitals and laboratories worldwide.
New Findings in Drug-Induced Receptor Activity
Wednesday, February 15, 2012
The discovery that drugs targeting a single GPCR can differentially modulate distinct subsets of the receptor signaling repertoire is a very important step in drug discovery.
A Modified MS2 Bacteriophage Plaque Reduction Assay for the Rapid Screening of Antiviral Plant Extracts
Tuesday, February 14, 2012
The ability of the MS2 plaque reduction assay to detect antiviral activity in these known antiviral plant preparations indicates its suitability as an antiviral screening tool.
Artel Grows Technical Services Team for Liquid Handling Quality Assurance
Monday, February 13, 2012
To support the expanded application of Artel technology and services.
Ironwood Pharmaceuticals Prices Public Offering of Common Stock
Monday, February 13, 2012
Company announces the pricing of an underwritten public offering of 5,250,000 shares of its Class A common stock at a price of $15.09 per share to the public.
Zalicus and Hydra Collaborate to Advance Novel Ion Channel Product Candidates for the Treatment of Pain
Monday, February 13, 2012
The goal of the collaboration is to advance ion channel drug candidates into clinical development for the treatment of pain.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 1 - 10 of 2678 |
|
|
